Barry D. Quart - Jun 6, 2023 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role: Director
Signature: /s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol: KNSA
Transactions as of: Jun 6, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/8/2023, 04:21 PM
Previous filing: Jan 20, 2023
Next filing: Jul 3, 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KNSA	Share Option	Award	$0	+26.2K		$0.00	26.2K	Jun 6, 2023	Class A Common Shares	26.2K	$15.19	Direct	F1
transaction	KNSA	Restricted Share Units	Award	$0	+4.37K		$0.00	4.37K	Jun 6, 2023	Class A Common Shares	4.37K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 6, 2023.
F2	Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F3	The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023.